Literature DB >> 9731261

Clinical, clinicopathologic, radiographic, and ultrasonographic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986-1995).

R S Hess1, H M Saunders, T J Van Winkle, F S Shofer, R J Washabau.   

Abstract

OBJECTIVE: To determine clinical, clinicopathologic, radiographic, ultrasonographic, and coagulation abnormalities in dogs in which acute pancreatitis was fatal.
DESIGN: Retrospective study. ANIMALS: 70 dogs. PROCEDURE: History, clinical signs, and physical examination findings at the time of initial evaluation at the veterinary teaching hospital; results of pretreatment laboratory tests, abdominal radiography, and ultrasonography; and histologic abnormalities were obtained from medical records.
RESULTS: Clinical signs included anorexia, vomiting, Weakness, diarrhea, polyuria and polydipsia, neurologic abnormalities, melena, weight loss, hematemesis, and passage of frank blood in feces. At the time of initial examination at the veterinary teaching hospital, 68 (97%) dogs were dehydrated, 18 (26%) were icteric, 22 (32%) were febrile, 40 (58%) had signs of abdominal pain, and 30 (43%) were classified as overweight or obese. Most dogs had leukocytosis, neutrophilia with a left shift, and thrombocytopenia. Various serum biochemical abnormalities were identified, including hypoglycemia, azotemia, hypercalcemia and other electrolyte abnormalities, hypoalbuminemia, high hepatic and pancreatic enzyme activities, hypercholesterolemia, and lipemia. For 17 of 28 (61%) dogs, results of coagulation function tests were abnormal. Results of abdominal ultrasonography and radiography were consistent with a diagnosis of acute pancreatitis in 23 of 34 (68%) and 10 of 41 (24%) dogs, respectively. For 2 dogs, results of abdominal ultrasonography were not suggestive of acute pancreatitis, but results of abdominal radiography were. CLINICAL IMPLICATIONS: Clinical signs and results of clinicopathologic tests are inconsistent. Abdominal ultrasonography may be valuable in the diagnostic evaluation of dogs suspected to have acute pancreatitis.

Entities:  

Mesh:

Year:  1998        PMID: 9731261

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  38 in total

1.  Changes in gene expression of tumor necrosis factor alpha and interleukin 6 in a canine model of caerulein-induced pancreatitis.

Authors:  Ruhui Song; Dohyeon Yu; Jinho Park
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

2.  Zinc toxicosis - Associated hemolytic anemia and pancreatic disease in 2 dogs.

Authors:  Kimberley Foote; Cornelia Gilroy; Shelley Burton; Barbara Horney; Alfonso Lopez; Christine Savidge; Tamara Goff
Journal:  Can Vet J       Date:  2020-02       Impact factor: 1.008

3.  Refinement of canine pancreatitis model: inducing pancreatitis by using endoscopic retrograde cholangiopancreatography.

Authors:  Dawn S Ruben; Diana G Scorpio; K L Gabrielson; B W Simon; Jonathan M Buscaglia
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

4.  A pilot study evaluating changes in pancreatic lipase immunoreactivity concentrations in canines treated with L-asparaginase (ASNase), vincristine, or both for lymphoma.

Authors:  Zachary Wright; Joerg Steiner; Jan Suchodolski; Kenita Rogers; Claudia Barton; Marjorie Brown
Journal:  Can J Vet Res       Date:  2009-04       Impact factor: 1.310

5.  Quantitative contrast-enhanced ultrasonographic assessment of naturally occurring pancreatitis in dogs.

Authors:  S Y Lim; K Nakamura; K Morishita; N Sasaki; M Murakami; T Osuga; N Yokoyama; H Ohta; M Yamasaki; M Takiguchi
Journal:  J Vet Intern Med       Date:  2014-09-30       Impact factor: 3.333

6.  Qualitative and quantitative contrast-enhanced ultrasonographic assessment of cerulein-induced acute pancreatitis in dogs.

Authors:  S Y Lim; K Nakamura; K Morishita; N Sasaki; M Murakami; T Osuga; H Ohta; M Yamasaki; M Takiguchi
Journal:  J Vet Intern Med       Date:  2014-02-24       Impact factor: 3.333

7.  Computed tomographic angiography under sedation in the diagnosis of suspected canine pancreatitis: a pilot study.

Authors:  A M Adrian; D C Twedt; S L Kraft; A J Marolf
Journal:  J Vet Intern Med       Date:  2014-10-01       Impact factor: 3.333

8.  Increased canine pancreatic lipase immunoreactivity (cPLI) and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) lipase in dogs with evidence of portal hypertension and normal pancreatic histology: a pilot study.

Authors:  Gonçalo Serrano; Dominique Paepe; Tim Williams; Penny Watson
Journal:  J Vet Diagn Invest       Date:  2021-04-02       Impact factor: 1.279

9.  Evaluation of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) and 1,2-diglyceride lipase assays in dogs with naturally occurring hypercortisolism.

Authors:  Guido Linari; Francesco Dondi; Sofia Segatore; Kateryna Vasylyeva; Nikolina Linta; Marco Pietra; Rodolfo O Leal; Federico Fracassi
Journal:  J Vet Diagn Invest       Date:  2021-06-02       Impact factor: 1.569

10.  Agreement of serum Spec cPL with the 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase assay and with pancreatic ultrasonography in dogs with suspected pancreatitis.

Authors:  P H Kook; N Kohler; S Hartnack; B Riond; C E Reusch
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.